🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to users administering substances of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Content Elimination

According to TikTok, the platform has removed violative material and banned associated keywords and query recommendations. The organization stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Activities

Research also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of members, populated with images of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at home.

After moments of entering one group, a vendor shared contact information, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Item Information and Pricing

Within these communities, messages display black plastic parcels with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her team has previously encountered patients harmed by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly serious medical dangers”.